NASDAQ:RARE | Cash Flow Statement | Ultragenyx Pharmaceutical Inc.

Complete source-backed cash-flow history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$92M
2026-03-31-$185M$8M-$197M$1M-$49M
2025-12-31-$128.56M$8.79M-$99.83M$938,000.00-$72.25M$394.19M
2025-09-30-$180.41M
2025-06-30-$115M
2025-03-31-$151M$9M-$166M$1M$120M$157,000.00
2024-12-31-$133.2M$9.54M-$79.32M$163,000.00$102.5M$2.95M
2024-09-30-$133.52M
2024-06-30-$131.6M
2024-03-31-$170.68M$8.85M-$190.73M$3.21M$94.44M-$58,000.00
2023-12-31-$123.55M$8.21M-$84.1M$1.33M-$107.02M$330.47M
2023-09-30-$159.65M
2023-06-30-$159.83M
2023-03-31-$163.97M$5.24M-$156.87M$25.03M$111.3M-$722,000.00
2022-12-31-$151.83M$4.96M-$90.34M$26.97M-$171.6M$1.88M
2022-09-30-$245.11M
2022-06-30-$158.16M
2022-03-31-$152.32M$4.09M-$117.52M$32.18M-$37.36M$1.61M
2021-12-31-$122.46M$3.53M-$54.34M$16.05M$69.06M$85.73M
2021-09-30-$73M
2021-06-30-$122.43M
2021-03-31-$136.14M$3.37M-$159.35M$16.41M-$182.42M$12.65M
2020-12-31-$24.01M$3.13M-$62.45M$21.95M$97.9M$489.71M
2020-09-30-$68.85M
2020-06-30$25.32M
2020-03-31-$119.03M$2.85M-$95.15M$14.1M-$95.13M$55.62M
2019-12-31-$93.81M$2.17M-$72.04M$11.5M$67.27M$315.44M
2019-09-30-$112.99M
2019-06-30-$99.17M
2019-03-31-$96.76M$2.12M-$95.78M$3.06M-$101.19M$353.62M
2018-12-31-$87.83M$2.94M-$55.85M$1.19M$73.56M$12.24M
2018-09-30-$87.31M
2018-06-30-$52.73M
2018-03-31$30.25M$6.16M-$89.48M$475,000.00-$71.03M$286.42M
2017-12-31-$81.73M$2.51M-$81.82M$899,000.00$57.39M$64.44M
2017-09-30-$79.23M
2017-06-30-$72.89M
2017-03-31-$68.29M$1.16M-$61.21M$485,000.00
2016-12-31-$71.29M$1.16M-$47.68M$666,000.00
2016-09-30-$64.91M
2016-06-30-$56.92M
2016-03-31-$52.76M$544,000.00-$44.9M$1.48M
2015-12-31-$55.22M$480,000.00-$40.44M$1.92M
2015-09-30-$39.23M
2015-06-30-$29.79M
2015-03-31-$21.38M$201,000.00-$17.66M$459,000.00
2014-12-31-$16.74M$212,000.00-$14.74M$453,000.00
2014-09-30-$15.85M
2014-06-30-$13.59M
2014-03-31-$13.63M$117,000.00-$8.34M$569,000.00-$65.4M$4.35M$121.75M
2013-12-31-$11.32M$112,000.00-$9.77M$129,000.00
2013-09-30-$8.43M
2013-06-30-$8.59M
2013-03-31-$6.74M$124,000.00-$6.29M$177,000.00-$15.1M$1,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$575M$35M-$466M$6M$236M$478M
2024-12-31-$569M$36M-$414M$7M-$18M$399M
2023-12-31-$607M$26M-$475M$44M$168M$388M
2022-12-31-$707.42M$18.22M-$380.47M$116.12M-$291.65M$501.21M
2021-12-31-$454.03M$13.24M-$338.7M$73.09M-$195.37M$118.55M
2020-12-31-$186.57M$12.26M-$132.22M$43.91M-$179.12M$600.27M
2019-12-31-$402.73M$8.54M-$345.38M$24.83M-$13.04M$679.31M
2018-12-31-$197.61M$19.54M-$290.57M$4.08M-$33.33M$336.85M
2017-12-31-$302.14M$5.83M-$253.84M$2.79M$55.48M$136.27M
2016-12-31-$245.87M$3.42M-$160.98M$10.19M$91.12M$138.68M
2015-12-31-$145.62M$1.38M-$105.98M$4.96M
2014-12-31-$59.8M$684,000.00-$44.63M$2.15M
2013-12-31-$35.07M$444,000.00-$31.2M$407,000.00
2012-12-31-$16.33M$313,000.00-$12.5M$1.09M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.